Shares of the maker of anti-obesity drugs Arena Pharmaceuticals (NASDAQ: ARNA) fell by more than 19% in October, according to data from S&P Global Market Intelligence.
Shares of the maker of anti-obesity drugs Arena Pharmaceuticals (NASDAQ: ARNA) fell by more than 19% in October, according to data from S&P Global Market Intelligence.